首页 › 基金 › ACUTA CAPITAL PARTNERS, LLC › ANTX
ACUTA CAPITAL PARTNERS, LLC 对 ANTX 的持仓历史
AN2 THERAPEUTICS INC · 医疗保健
ACUTA CAPITAL PARTNERS, LLC 在 Q3 2026 的 13F 申报中披露持有 ANTX(AN2 THERAPEUTICS INC)142,051 股,市值约 US$756K,约占其申报组合的 0.60%,在其申报持仓中市值排名第 29 位。 ACUTA CAPITAL PARTNERS, LLC 最近 13 个申报季度中有 3 个季度披露了 ANTX 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
ACUTA CAPITAL PARTNERS, LLC 对 ANTX 的持仓演变
ACUTA CAPITAL PARTNERS, LLC 于 Q3 2023 首次披露 ANTX 持仓:13,300 股(约 US$214K)。 该持仓在 Q4 2023 达到峰值 132,000 股,市值约 US$2.7M。 在 3 次申报中,ACUTA CAPITAL PARTNERS, LLC 1 次增持、0 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 142,051 股、市值约 US$756K。 持仓曾出现大幅变动:Q4 2023 增持约 892% (随后一个季度股价下跌 84%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 13.30K | $213.86K | 新进 |
| Q4 2023 | 132.00K | $2.70M | 增持 |
| Q3 2026 | 142.05K | $755.71K | 新进 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ANTX 与 13F 数据
ANTX(AN2 THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 46 只申报持有 ANTX,申报仓位最大的包括:Vivo Capital, LLC (US$16.8M), Commodore Capital LP (US$14.2M), Spruce Street Capital LP (US$9.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ANTX 的基金
- Vivo Capital, LLC 3.15M 股 · $16.78M · Q3 2026
- Commodore Capital LP 2.93M 股 · $14.20M · Q2 2026
- Spruce Street Capital LP 1.75M 股 · $9.32M · Q3 2026
- Almitas Capital LLC 1.47M 股 · $7.11M · Q2 2026
- ACORN CAPITAL ADVISORS, LLC 1.30M 股 · $6.92M · Q3 2026
- Boxer Capital Management, LLC 749.03K 股 · $3.63M · Q2 2026
- Tetragon Partners GP Ltd 603.42K 股 · $3.21M · Q3 2026
- Sio Capital Management, LLC 548.10K 股 · $2.92M · Q3 2026
- Ally Bridge Group (NY) LLC 526.32K 股 · $2.55M · Q2 2026
- Aldebaran Capital, LLC 367.71K 股 · $1.96M · Q3 2026
- Prosight Management, LP 350.88K 股 · $1.87M · Q3 2026
- Stonepine Capital Management, LLC 350.88K 股 · $1.87M · Q3 2026
更多关于 ACUTA CAPITAL PARTNERS, LLC
常见问题
How long has ACUTA CAPITAL PARTNERS, LLC held ANTX?
ACUTA CAPITAL PARTNERS, LLC has disclosed ANTX holdings in 3 of the last 13 reported quarters, going back to Q3 2023.
What is ACUTA CAPITAL PARTNERS, LLC's current position in ANTX?
As of Q3 2026, ACUTA CAPITAL PARTNERS, LLC holds 142.05K shares of ANTX (AN2 THERAPEUTICS INC), valued at $755.71K, representing 0.60% of its reported portfolio and ranking #29.
Has ACUTA CAPITAL PARTNERS, LLC been buying or selling ANTX?
In the latest 13F filing (Q3 2026), ACUTA CAPITAL PARTNERS, LLC newly opened its position in ANTX. The position peaked in Q4 2023 at 132.00K shares.
Which other funds hold ANTX?
Other major institutional holders of ANTX include Vivo Capital, LLC, Commodore Capital LP, Spruce Street Capital LP, among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.